Articles by Larry Bilbrey

OneOncology's Larry Bilbrey discusses why unstructured data limits artificial intelligence and how practices can weigh AI purchases by their payoff.

Why EOM Participation Was Extremely Low—and How to Fix It
ByAaron Lyss, MBA,Brian Kern, JD,Joe Abrams, BS,Garrett Young, BA,Leah Owens, DNP, RN, BMTCN, OCN,Larry Bilbrey,Natalie R. Dickson, MD, MMHC, FACP, FASCO